Jung‐Ta Chen
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 3
- Oncology 11
- Cancer-related Molecular Pathways 3
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Cheng‐Chung Wu (7 shared papers)Shiou‐Hwei Yeh (2 shared papers)Pei‐Jer Chen (2 shared papers)Ri‐Yao Yang (2 shared papers)Fu‐Tong Liu (2 shared papers)Daniel K. Hsu (2 shared papers)Esther Shih‐Chu Ho (6 shared papers)Fu-Shing Liu (5 shared papers)
- Journals
- International Journal of Cancer (5 papers)Surgery (4 papers)Gynecologic Oncology (3 papers)Cancer (2 papers)Toxicologic Pathology (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Jung‐Ta Chen
34 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Hepatology 290
- Cancer Research 246
- Oncology 352
- Reproductive Medicine 83
- Immunology 192
Countries citing papers authored by Jung‐Ta Chen
This map shows the geographic impact of Jung‐Ta Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Ta Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Ta Chen more than expected).
Fields of papers citing papers by Jung‐Ta Chen
This network shows the impact of papers produced by Jung‐Ta Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Ta Chen. The network helps show where Jung‐Ta Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jung‐Ta Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 189 | |
| 2 | 1999 | 168 | |
| 3 | 2001 | 83 | |
| 4 | 2005 | 76 | |
| 5 | 2003 | 73 | |
| 6 | 2001 | 72 | |
| 7 | 2003 | 64 | |
| 8 | 2001 | 62 | |
| 9 | 1999 | 59 | |
| 10 | 1999 | 58 | |
| 11 | 2000 | 53 | |
| 12 | 2004 | 44 | |
| 13 | 2002 | 38 | |
| 14 | 2003 | 36 | |
| 15 | 1996 | 35 | |
| 16 | 2004 | 34 | |
| 17 | 2001 | 34 | |
| 18 | KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer. | 2003 | 34 |
| 19 | 2003 | 31 | |
| 20 | 2001 | 31 |
About Jung‐Ta Chen
Jung‐Ta Chen is a scholar working on Molecular Biology, Oncology, Hepatology, Surgery and Cancer Research, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Genetic factors in colorectal cancer (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Hepatology (290 citations), Cancer Research (246 citations), Oncology (352 citations), Reproductive Medicine (83 citations) and Immunology (192 citations). Jung‐Ta Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Cheng‐Chung Wu, Shiou‐Hwei Yeh, Pei‐Jer Chen, Ri‐Yao Yang, Fu‐Tong Liu, Daniel K. Hsu, Esther Shih‐Chu Ho, Fu-Shing Liu, Yeun-Ting Hsieh and Man‐Jung Hung. Their work appears in journals such as International Journal of Cancer, Surgery, Gynecologic Oncology, Cancer and Toxicologic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.